Business Update15 Mar 2024, 12:29 am
GUFIC Biosciences Granted Patent for Dalbavancin Lyophilized Pharmaceutical Composition for 20 Years
AI Summary
GUFIC Biosciences Limited has announced the granting of a patent for an invention titled 'LYOPHILIZED PHARMACEUTICAL COMPOSITIONS OF DALBAVANCIN'. The patent, effective from November 23, 2016, was granted under the Patents Act, 1970 for a term of 20 years. GUFICBIO's stock symbol is GUFICBIO.
Key Highlights
- GUFIC Biosciences Limited granted a patent for Dalbavancin Lyophilized Pharmaceutical Composition
- Patent effective from November 23, 2016, for a term of 20 years
- Patent granted in accordance with the Patents Act, 1970